InVivoMAb anti-mouse LFA-1alpha (CD11a)
BE0005-1
ApplicationsNeutralisation/Blocking
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse LFA-1alpha (CD11a)
- Delivery Days Customer7
- ApplicationsNeutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDFD441.8
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostRat
- IsotypeIgG2b
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Su CA, Iida S, Abe T, et al. Endogenous memory CD8 T cells directly mediate cardiac allograft rejection. Am J Transplant. 2014,14(3):568-79. doi: 10.1111/ajt.12605Read this paper
- Setoguchi K, Hattori Y, Iida S, et al. Endogenous memory CD8 T cells are activated within cardiac allografts without mediating rejection. Am J Transplant. 2013,13(9):2293-307. doi: 10.1111/ajt.12372Read this paper
- Ashkenazi E, Baranovski BM, Shahaf G, et al. Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4/CD8 therapy. PLoS One. 2013,8(5):e63625. doi: 10.1371/journal.pone.0063625Read this paper
- Setoguchi K, Schenk AD, Ishii D, et al. LFA-1 antagonism inhibits early infiltration of endogenous memory CD8 T cells into cardiac allografts and donor-reactive T cell priming. Am J Transplant. 2011,11(5):923-35. doi: 10.1111/j.1600-6143.2011.03492.xRead this paper
- Kish DD, Volokh N, Baldwin WM 3rd, et al. Hapten application to the skin induces an inflammatory program directing hapten-primed effector CD8 T cell interaction with hapten-presenting endothelial cells. J Immunol. 2011,186(4):2117-26. doi: 10.4049/jimmunol.1002337Read this paper
- James SE, Orgun NN, Tedder TF, et al. Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice. Blood. 2009,114(27):5454-63. doi: 10.1182/blood-2009-08-232967Read this paper
